BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15077593)

  • 1. [Nimesulide: a lower risk treatment in rheumatic diseases].
    Trnavský K
    Vnitr Lek; 2004 Feb; 50(2):157-62. PubMed ID: 15077593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
    Gibofsky A
    J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pain therapy in rheumatism. After 65 years of age coxibs are the best choice].
    MMW Fortschr Med; 2003 Oct; 145(42):60. PubMed ID: 14655447
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis.
    Suárez-Otero R; Robles-San Román M; Jaimes-Hernández J; Oropeza-De La Madrid E; Medina-Peñaloza RM; Rosas-Ramos R; Castañeda-Hernández G
    Proc West Pharmacol Soc; 2002; 45():26-8. PubMed ID: 12434517
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
    Joshua FF; Oakley SP; Major GA
    Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tramadol pharmacokinetics and its possible interactions with cyclooxygenase 2-selective nonsteroidal anti-inflammatory drugs.
    Punwani NG
    Clin Pharmacol Ther; 2004 Apr; 75(4):363-5. PubMed ID: 15060515
    [No Abstract]   [Full Text] [Related]  

  • 7. Coxibs and cardiovascular risk.
    Allen MJ; McLean-Veysey P; Fleming I
    CMAJ; 2005 Oct; 173(8):853. PubMed ID: 16217098
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy with COX-2 inhibitors. Less risk--better tolerance].
    MMW Fortschr Med; 2000 Dec; 142(49-50):65-6. PubMed ID: 11190944
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of efficacy of nizer versus nimesulide tablets in otitis media.
    Dasgupta KS; Deshpande AS; Vedi JN; Patel S
    J Indian Med Assoc; 2002 Oct; 100(10):619. PubMed ID: 12452517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 11. Nimesulide -- a multifactorial approach to inflammation and pain: scientific and clinical consensus.
    Rainsford KD;
    Curr Med Res Opin; 2006 Jun; 22(6):1161-70. PubMed ID: 16846549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antipyretic effect of nimesulide and paracetamol in children attending a secondary level hospital.
    Kapoor SK; Sharma J; Batra B; Paul E; Anand K; Sharma D
    Indian Pediatr; 2002 May; 39(5):473-7. PubMed ID: 12037280
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recommendations for treatment with nonsteroidal anti-inflammatory drugs].
    Bolten WW
    MMW Fortschr Med; 2005 Aug; 147(31-32):24-7. PubMed ID: 16128192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing the risks and benefits of celecoxib.
    Caldwell B; Beasley R; Weatherall M; Metcalfe S
    Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
    Fenn GC; Grobler M; Schaffer D
    Intern Med J; 2004 Nov; 34(11):647-9; discussion 650. PubMed ID: 15546461
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe ulcers on celecoxib.
    Prescrire Int; 2002 Dec; 11(62):182-3. PubMed ID: 12472096
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progress in therapy of rheumatism. New coxib works especially fast].
    MMW Fortschr Med; 2003 Jun; 145(23):58. PubMed ID: 12854230
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nimesulide spectrophotometric determination in the visible region].
    Perju AC; Mândrescu M; Spac AF; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):535-9. PubMed ID: 17983199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib and the CLASS trial: data massaging by industry.
    Prescrire Int; 2002 Dec; 11(62):190-1. PubMed ID: 12472103
    [No Abstract]   [Full Text] [Related]  

  • 20. Allergic vasculitis associated with celecoxib.
    Jordan KM; Edwards CJ; Arden NK
    Rheumatology (Oxford); 2002 Dec; 41(12):1453-5. PubMed ID: 12468830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.